|
Plenary Lecturers
Graham Collingridge (Bristol) Insights into the molecular
basis of memory
Salvador Moncada (London) Nitric oxide, bioenergetics and
cell signaling
John Lowry (Conway, Ireland) In Vivo Voltammetry: Real-Time
Monitoring of Brain Chemistry
Edvard Moser (Oslo) Entorhinal grid cells and hippocampal
memory
Yves Barde (Switzerland) Neurotrophins in development and
diseases
Helen Mayberg (Atlanta) Paths To Recovery: Modulating Putative
Depression Circuits using Deep Brain Stimulation
Joe LeDoux (New York) Rembrance of Emotions Past: A View
Through Fear
Symposia
The Neuropathology of Autism: recent advances in understanding
neurochemical mechanisms.
Chair Gene Blatt
Speakers
Gene Blatt (Boston) Neurochemical Alterations in the Cerebellar
and Limbic Systems in Autism
Jane Yip (Boston) Functional status of cerebellar Purkinje
cells in autism
Elaine Perry (Newcastle) Cholinergic systems in autism
Phil Luthert (Oxford) Neuroanatomcal substrates of autism
Payam Rezaie (Open University, Milton Keynes) Glial cells
within the cerebral cortex in autism
Ubiquitination Dependent Regulation of Synaptic Development
and Plasticity.
Chair Josef Kittler.
Speakers: Michael Ehlers (Durham) Bidirectional
Control of Glutmatergic Synapses by Postsynaptic Ubiquitination
Andrea Brand (Cambridge) Control of synaptic development
by the Anaphase Promoting Complex/Cyclosome
Scott Wilson (Alabama) Regulation of synaptic function
by ubiquitin-specific protease 14
Jeremy Henley (MRC, Bristol): SUMOylation Regulates Kainate
Receptor Mediated Synaptic Transmission
Neuroreparative approaches using stem cell biology.
Chair Stefan Przyborski
Speakers:
Maeve Caldwell (Cambridge) Neural stem cell therapy for
Parkinsons Disease
Sue Barnett (Glasgow) Are there stem cells in the olfactory
system
Anne Rosser (Cardiff): Finding cells for replacement therapy
in Huntington's disease
Siddarthan Chandran (Cambridge) Embryonic solutions for
adult problems
back
to top
A role for inflammation in neurodegeneration: Where do
we stand? *
Chair Tom Connor
Speakers:
Thomas Connor (Dublin) Noradrenergic control of inflammatory
processes in the CNS
Marina Lynch (Dublin) Neuronal-glial interactions, inflammation
and synaptic function
Daniel Anthony (Oxford) The systemic control of acute and
chronic inflammation in the brain
Robin Franklin (Cambridge) Inflammation and CNS remyelination
Cannabinoids: fate, food and fear. *
Chair Veronica Campbell
Speakers:
Veronica Campbell (Dublin) The influence of cannabinoids
on neural fate.
Tim Kirkham (Liverpool) Cannabinoids, appetite and obesity
David Finn (Galway) Endocannabinoid-mediated modulation
of fear-related behaviour: sites and mechanisms of action
Ruth Ross (Aberdeen) Cannabinoid Neuropharmacology: recent
developments
Purines in physiology, plasticity and pathology.
Chair Bruno Frenguelli
Speakers:
Phil Haydon (Pennsylvania) Astrocytic purinergic signaling
coordinates synaptic networks
Nick Dale (Warwick) Mechanisms of adenosine release in
the basal forebrain and the control of sleep
Alex Gourine (UCL) The role of ATP in the brain mechanisms
controlling breathing
Detlev Boison (Portland) Adenosine, astrogliosis and epilepsy:
a rational approach for novel cell and gene therapies
back
to top
Circadian Rhythms in the Brain.
Chair Ela Pyza and Hugh Piggins.
Speakers:
Hugh Piggins (Manchester) Behavioural Feedback and Circadian
Rhythms
Jolanta Zawilska (Poland) Melatonin in the avian retina
and pineal gland - photic, circadian and neurochemical regulations
Michael Nitabach (USA) Membranes, Ions and Clocks: Cellular
Physiology of Pacemaker Neurons
Ela Pyza Circadian plasticity of neurons and glial cells
Sleep and Anaesthesia: common mechanisms?
Chair Bill Wisden
Speakers:
Nick Franks (London) General anaesthesia and sleep pathways
Helmut Haas (Germany) Gabaergic inhibition of wake-active
neurons
Synaptic Origami: protein folding at the synapse
Chair Vincent O Connor and Andreas Wyttenbach
Speakers:
Ulrich Hartl (Munich) Molecular Chaperone as modulators
of proteotoxicity in neurodegenerative disease
Paul Skehel (Edinburgh) VAP proteins and neurodegeneration
Konrad Zinsmaier (Arizona) Synaptic function of the Synaptic
Vesicle-associated CSP/Hsc70 Chaperone#
Giovanna Mallucci (London) Targeting cellular prion protein
reverses early cognitive deficits and neurophysiological dysfunction
in prion-infected mice.
back
to top
Emotion and Cognition: anatomical substrates and therapeutic
targets.
Chair Colin Ingram
Speakers:
John Cryan (Cork) Novel Therapeutic targets for stress-related
disoorders
Hugh Garavan (Dublin) Neuroanotomical substrates and disorders
of frontal-lobe related cognitive processes
Subcellular and proteomic approaches to dissect neuronal
signalling pathways
Chair Ralf Schoepfer
Speakers:
Jan Van Minnen (Netherlands) Cellular and proteomics approaches
to protein synthesis in axons
Seth Grant (Cambridge) Evolution and diversity of the synapse
proteome
Ralf Schoepfer (UCL) Posttranslational modifications and
signaling in postsynaptic densities
From cell-cell recognition to memory formation
Chair Mike Stewart
Speakers:
Elisabeth Bock (Denmark) Structural biology of neuronal
cells adhesion molecules and their counter receptors
Michael Stewart (Milton Keynes) The role of cell adhesion
molecules (CAMs) and CAM mimetics in synaptic plasticity:
ultrastructural studies.
Carmen Sandi (Switzerland) Role of cell adhesion molecules
in memory consolidation and cognitive flexibility
back
to top
Alcohol: molecular and cellular mechanisms of intoxication,
tolerance and addiction
Chair Lindy Holden-Dye
Speakers:
Dai Stephens (Sussex) Measuring motivation for moonshine
in mutant mice; altered responses to booze and drugs in mice
with mutations of GABAA receptor alpha subunits
Hilary Little (London) Alcohol, stress and memory
Rachel French (California) Drosophila as a genetic model
for ethanol-induced neurodegeneration
Multi-sensory Processes *
Chair Fiona Newell
Speakers:
Fiona Newell (Dublin) Synaesthesia: a window into the genetic
basis of multisensory processing
John Foxe (Dublin) How fast is multisensory integration
in human cortex?
Stuart Smith (Dublin) A Multisensory spin on self-motion
perception
Gemma Calvert (Bath) A combined intracranial EEG, MEG and
fMRI look at audiovisual speech integration.
Alzheimer's Disease: current therapies and progress on
the development of drugs to slow disease progression
Chair Mike O Neill and Eric Karran
Speakers:
Richard Mohs (Indianapolis) Alzheimer's Disease is a Worldwide
Problem: The Burden and Current Standards of Care
Menelas Pangalos (New Jersey) An over-view of Beta-amyloid
approaches
Peter Davis (New York) What is the significance of tau
pathology in Alzheimer's disease?
Rachael Scahill (UCL) The Use of MRI for Tracking Disease
Progression and Assessment of Novel Therapies in Alzheimer's
Disease
Discovering drug effects through functional brain imaging
Chair Ingo Schiessl
Speakers:
Michael James (Essex) TBC
Steve Williams (Manchester) Probing Serotonin and Glutamate
Actions on the Brain in vivo: Pharmacological Challenge fMRI
in animal models and human volunteers
Nicola Sibson (Oxford) Modulating neuronal and haemodynamic
responses: coupling and uncoupling
Ingo Schiessl (Manchester) Analysis of pMRI data with Blind
Source Seperation
back
to top
Hippocampal neurogenesis in mood disorders and their treatment.
Sponsored by British Association for Psychopharmacology
Chair Clare Stanford and Kevin Fone
Speakers:
Erica Glasper (Yale) Neurogenesis: the key to depression
and its treatment?
Eberhard Fuchs (Gottingen) Adult neurogenesis is susceptible
to chronic stress
Jaime McCutcheon (UCL) Genetic background influences neurogenesis
and other associated phenotypes in the NK1-/- mouse
Ian Reid (Aberdeen) Brain Plasticity and anytidepressant
treatments: new cells, new connections
Basal Ganglia subcortical connections: exploring the brainstem.
Chair Paul Bolam and Philip Winn
Speakers
Philip Winn (St Andrews) Behavioural roles of the PPtg
Juan Mena-Segovia (Oxford) Physiological analyses of cholinergic
and non-cholinergic neurons in the PPN that innervate the
basal ganglia
Dipankar Nandi (Oxford) The role of the pedunculopontine
nucleus in Parkinson’s disease
Peter Redgrave (Sheffield) Subcortical loops and through
the basal ganglia
Thalamocortical development
Chair Zoltan Molnar
Speakers:
Nobuhiko Yamamoto (Japan) Activity Independent and Dependent
Mechanisms for the Formation of the Thalamocortical Projection
Kevin Mitchell (Dublin) Specificity and plasticity in thalamocortical
connectivity: lessons from Semaphorin-6A mutant mice
Guillermina Lopez-Bendito (Spain) Tangential Neuronal Migration
Controls Axon Guidance: A Role for Neuregulin-1 in Thalamocortical
Axon Navigation
David Price (Edinburgh) Molecular regulation of thalamocortical
axonal navigation
New mutant models for neurodevelopmental and neurodegenerative
disorders *
Chair John Waddington
Speakers
Dairin Kieran ( RCS) SOD1mt-PUMA double mutants in relation
to amytrophic lateral sclerosis
Kevin Mitchell (Dublin) Semaphorin and Plexin mutants as
models for disorders of connectivity
Elizabeth Fisher (London) An aneuploid mouse with a human
chromosome modelling Down Syndrome
Colm O'Tuathaigh (RCS) Dissecting the genetic contribution
to psychosis: new evidence from susceptibility gene mutants
* Coordinated by Neuroscience Ireland
For further information: bna2007@bna.org.uk,
tel: 0151 794 4943/5449
back
to top
**********************************************
|
